Modulation of ligand binding to components of the GABAA receptor complex by ammonia: Implications for the pathogenesis of hyperammonemic syndromes

Brain Research

Volumn 720, Issue 1-2, 1996, Pages 35-44

  Ha, Jeoung Hee ^a,b   Basile, Anthony S ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b Yeungnam University College of Medicine   (South Korea)

Author keywords

Ammonia; Flunitrazepam; GABAA receptor; Liver failure; Muscimol

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BENZODIAZEPINE;

ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; CONTROLLED STUDY; HYPERAMMONEMIA; LIVER FAILURE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING;

EID: 0030003924     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00104-7     Document Type: Article

References (51)

1. Alger, B.E. and Nicoll, R.A., Ammonia does not selectively block IPSPs in rat hippocampal pyramidal cells, J. Neurophysiol., 49 (1983) 1381-1391.
2. Arn, P.H., Hauser, E.R., Thomas, G.H., Herman, G., Hess, D. and Brusilow, S.W., Hyperammonemia in women with a mutation at the ornithine carbamoyl transferase locus, New Engl. J. Med., 322 (1990) 1652-1655.
3. Basile, A.S., The contribution of endogenous benzodiazepine receptors to the pathogenesis of hepatic encephalopathy, Synapse, 7 (1991) 141-150.
4. Basile, A.S., Gammal, S.H., Jones, E.A. and Skolnick, P., Characterization of the GABA-benzodiazepine receptor supramolecular complex in thioacetamide-treated rats: evidence for the presence of endogenous ligands for the benzodiazepine receptor in hepatic encephalopathy, J. Neurochem., 53 (1989) 1057-1063.
5. Basile, A.S., Jones, E.A. and Skolnick, P., The pathogenesis of hepatic encephalopathy: evidence for the involvement of benzodiazepine receptor ligands, Pharmacol. Rev., 43 (1991) 27-69.
6. 3H]PK 11195 binding, J. Pharmacol. Meth., 17 (1987) 149-156.
7. Bassett, M.L., Mullen, K.D., Scholz, B., Fenstermacher, J.D. and Jones, E.A., Increased brain uptake of γ-aminobutyric acid in a rabbit model of hepatic encephalopathy, Gastroenterol., 98 (1990) 747-757.
8. Browner, M., Ferkany, J.W. and Enna, S.J., Biochemical identification of pharmacologically and functionally distinct GABA receptors in rat brain, J. Neurosci., 1 (1981) 514-518.
9. 1H-NMR spectroscopy and biochemical investigation, Hepatol., 12 (1990) 281-290.
10. Butterworth, R.F., Giguère, J-F., Michaud, J., Lavoie, J. and Layrargues, G.P., Ammonia: Key factor in the pathogenesis of hepatic encephalopathy, Neurochem. Path., 6 (1987) 1-12.
11. Conn, H.O., Hepatic encephalopathy. In L. Schiff and E.R. Schiff (Eds.), Diseases of the Liver, J.B. Lippincott Co., Philadelphia, PA, 1993, pp. 1036-1060.
12. Cooper, A.J.L. and Plum, F., Biochemistry and physiology of brain ammonia, Physiol. Rev., 67 (1987) 440-519.
13. Corda, M.G. and Biggio, G., Stress and GABAergic transmission: biochemical and behavioral studies. In G. Biggio and E. Costa (Eds.), GABAergic Transmission and Anxiety, Raven Press, New York, NY, 1986, pp. 121-136.
14. Crossley, I.R., Wardle, E.N. and Williams, R., Biochemical mechanisms of hepatic encephalopathy, Clin. Sci., 64 (1983) 247-252.
15. Dombro, R.S., Hutson, D.G. and Norenberg, M.D., The action of ammonia on astrocyte glycogen and glycogenolysis, Mol. Chem. Neuropathol., 19 (1993) 259-268.
16. Enna, S.J. and Snyder, S.H., Influences of ions, enzymes and detergents on γ-aminobutyric acid-receptor binding in synaptic membranes of rat brain, Mol. Pharmacol., 13 (1977) 442-453.
17. Flannery, D.B., Hsia, Y.E. and Wolf, B., Current status of hyperammonemia syndromes, Hepatol., 2 (1982) 495-506.
18. A receptor antagonist activity to rat brain, Neuropharmacol., 25 (1986) 1279-1283.
19. Hilgier, W. and Olson, J.E., Brain ion and amino acid contents during edema development in hepatic encephalopathy, J. Neurochem., 62 (1994) 197-204.
20. Hindfelt, B., Plum, F. and Duffy, T.E., Effect of acute ammonia intoxication on cerebral metabolism in rats with portacaval shunts, J. Clin. Invest., 59 (1977) 386-396.
21. Iles, J.F. and Jack, J.J.B., Ammonia: assessment of its action on postsynaptic inhibition as a cause of convulsions, Brain, 103 (1983) 555-578.
22. Jessy, J., DeJoseph, M.R. and Hawkins, R.A., Hyperammonemia depresses glucose consumption throughout the brain, Biochem. J., 277 (1991) 693-696.
23. Leeb-Lundberg, F., Snowman, A. and Olsen, R.W., Barbiturate receptor sites are coupled to benzodiazepine receptors, Proc. Natl. Acad. Sci. USA, 77 (1980) 7468-7472.
24. Lux, H.D., Ammonium and chloride extrusion. Hyperpolarizing synaptic inhibition in spinal motoneurons, Science, 173 (1971) 555-557.
25. Lux, H.D. and Neher, E., The action of ammonium on postsynaptic inhibition of cat spinal motoneurons, Exp. Brain Res., 11 (1970) 431-447.
26. 3H-diazepam to rat brain, Proc. Soc. Exp. Biol. Med., 158 (1978) 393-397.
27. Mans, A.M., Biebuyck, J.F., Saunders, S.J., Kirsch, R.E. and Hawkins, R.A., Correlation of plasma and brain amino acid and putative neurotransmitter alterations during acute hepatic coma in the rat, J. Neurochem., 32 (1979) 285-292
28. Mohler, H. and Okada, T., The benzodiazepine receptor: demonstration in the central nervous system, Science, 198 (1977) 849-851.
29. Mullen, K.D., Szauter, K.M. and Kaminsky-Russ, K., 'Endogenous' benzodiazepine activity in physiological fluids of patients with hepatic encephalopathy, Lancet, ii (1990) 81-83.
30. Nieto, C., Arias, J., Alsasua, A. and Garcia de Jalon, P.D., Changes in brain oxidative metabolism in rats with portocaval shunt, Experientia, 36 (1980) 1403-1404.
31. Norenberg, M.D., The role of astrocytes in hepatic encephalopathy, Neurochem. Pathol., 6 (1987) 13-33.
32. Norenberg, M.D., Mozes, L.W., Papendick, R.E. and Norenberg, L.O.B., Effect of ammonia on glutamate, GABA and rubidium uptake by astrocytes, Ann. Neurol., 18 (1985) 149.
33. Oja, S.S., Saransaari, P., Wysmyk, U. and Albrecht, J., Loss of GABAB binding sites in the cerebral cortex of rats with acute hepatic encephalopathy, Brain Res., 629 (1993) 355-357.
34. Olsen, R.W. and Snowman, A.M., Chloride-dependent enhancement by barbiturates of γ-aminobutyric acid receptor binding, J. Neurosci., 2 (1982) 1812-1823.
35. A receptor by depressant barbiturates and pregnane steroids, Br. J. Pharmacol., 94 (1988) 1257-1269.
36. Plum, F. and Hindfelt, B., The neurological complications of liver disease, In P.H. Vinken and G.W. Bruyn (Eds.), Handbook of Clinical Neurology, Vol. 27, Elsevier, New York, 1976, pp. 349-378.
37. Raabe, W., Neurophysiology of ammonia intoxication, In R. Butterworth and G. Pomier-Layrargues (Eds.), Hepatic Encephalopathy. Pathophysiology and Treatment, Humana Press, Clifton, NJ, 1989, pp. 49-77.
38. Raabe, W. and Gumnit, R.J., Disinhibition in cat motor cortex by ammonia, J. Neurophysiol., 38 (1975) 347-355.
39. 2+, J. Neurochem., 62 (1994) 916-922.
40. Squires, R.F. and Saederup, E., γ-Aminobutyric acid receptors modulate cation binding sites coupled to independent benzodiazepine, picrotoxin, and anion binding sites, Mo. Pharmacol., 22 (1982) 327-334.
41. Subbalakshmi, G.Y.C.V. and Murthy, C.R.K., Acute metabolic effects of ammonia on the enzymes of glutamate metabolism in isolated astroglial cells, Neurochem. Int., 5 (1983) 593-597.
42. Swain, M., Butterworth, R.F. and Blei, A.T., Ammonia and related amino acids in the pathogenesis of brain edema in acute ischemic liver faiure in rats, Hepatol., 15 (1992) 449-453.
43. A response in dissociated rat cortical neurons, Neurosci. Lett., 151 (1993) 51-54.
44. Theoret, Y. and Bossu, J.L., Effects of ammonium salts on synaptic transmission to hippocampal CA1 and CA3 pyramidal cells in vivo, Neuroscience, 14 (1985) 807-821.
45. Theoret, Y., Davies, M.F., Esplin, B. and Capek, R., Effects of ammonium chloride on synaptic transmission in the rat hippocampal slice, Neuroscience, 14 (1985) 798-806.
46. Tossman, U., Delin, A., Eriksson, S. and Ungerstedt, U., Brain cortical amino acids measured by intracerebral dialysis in portacaval shunted rats, Neurochem. Res., 12 (1987) 265-269.
47. van der Rijt, C.C.D., de Knegt, R.J., Schalm, S.W., Terpstra, O.T. and Mechelse, K., Flumazenil does not improve hepatic encephalopathy associated with acute ischemic liver failure in the rabbit, Metab. Brain Dis., 5 (1990) 131-141.
48. Vergara, F., Plum, F. and Duffy, T.E., α-Ketoglutaramate: Increased concentrations in the cerebrospinal fluid of patients in hepatic coma, Science, 183 (1974) 81-83.
49. 3H]muscimol, a potent γ-aminobutyric acid agonist, to rat brain synaptosomal membranes using a filtration assay, J. Neurochem., 32 (1979) 713-718.
50. Willow, M. and Johnston, G.A.R., Dual action of pentobarbitone on GABA binding: role of binding site integrity, J. Neurochem., 37 (1981) 1291-1294.
51. Wysmyk, U., Oja, S.S., Saransaari, P. and Albrecht, J., Enhanced GABA release in cerebral cortical slices derived from rats with thioacetamide-induced hepatic encephalopathy, Neurochem. Res., 17 (1992) 1187-1190.